Campbell Shannon 4
4 · Black Diamond Therapeutics, Inc. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Campbell Shannon
Director
Transactions
- Award
Common Stock
2024-06-21$4.98/sh+2,011$10,015→ 2,011 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Fifth Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 20, 2024.